Viana Raquel, Wang Renwei, Yu Mimi C, Welschinger Robert, Chen Chien-Yu, Kew Michael C
MRC/University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand Medical School, Johannesburg, South Africa.
J Med Virol. 2009 Sep;81(9):1525-30. doi: 10.1002/jmv.21574.
Although viral loads are known to influence the development of hepatitis B virus-induced hepatocellular carcinoma in a number of populations, little information is available in the Black African population. Black African patients with hepatocellular carcinoma differ from those in other populations in having a lower frequency of e antigen-positivity and in other respects that might affect viral loads. Hepatitis B viral loads were measured using real-time polymerase chain reaction assay in 124 Black Africans with hepatocellular carcinoma and compared with those in 125 Black adult asymptomatic viral carriers. The geometric mean viral load in the cancer patients was 553,618 copies/ml (95% CI 301,953-1,015,033 copies/ml), with 62.1% having loads >1 x 10(5) copies/ml and 87.1% >1 x 10(4) copies/ml, whereas that in the carriers was 16,084 copies/ml (95% CI 9,184-28,168 copies/ml), with only 15.2% having values >1 x 10(5) copies/ml and 49.6% >1 x 10(4) copies/ml (P < 0.001 in each instance). Mean viral load was significantly higher in e antigen-positive than e antigen-negative cancer patients (5,905,357 copies/ml [1,362,847-25,588,520] cf 238,173 copies/ml [97,200-685,730]: P < 0.001) after adjusting for age and sex. No statistically significant difference existed between patients in different age groups, in men and women, or in patients infected with genotype A or D after adjusting for the other variables.
Black Africans with hepatocellular carcinoma have high hepatitis B viral loads in spite of the relative infrequency of e antigen-positivity.
尽管已知病毒载量会在许多人群中影响乙型肝炎病毒诱发的肝细胞癌的发展,但关于非洲黑人人群的相关信息却很少。患有肝细胞癌的非洲黑人患者与其他人群不同,其e抗原阳性频率较低,且在其他可能影响病毒载量的方面也有所差异。采用实时聚合酶链反应检测法对124例患有肝细胞癌的非洲黑人进行了乙型肝炎病毒载量测定,并与125例无症状成年黑人病毒携带者的病毒载量进行了比较。癌症患者的病毒载量几何平均值为553,618拷贝/毫升(95%可信区间301,953 - 1,015,033拷贝/毫升),其中62.1%的患者病毒载量>1×10⁵拷贝/毫升,87.1%的患者>1×10⁴拷贝/毫升;而携带者的病毒载量几何平均值为16,084拷贝/毫升(95%可信区间9,184 - 28,168拷贝/毫升),只有15.2%的携带者病毒载量>1×10⁵拷贝/毫升,49.6%的携带者>1×10⁴拷贝/毫升(在每种情况下P<0.001)。在对年龄和性别进行校正后,e抗原阳性的癌症患者的平均病毒载量显著高于e抗原阴性的癌症患者(5,905,357拷贝/毫升[1,362,847 - 25,588,520]对比238,173拷贝/毫升[97,200 - 685,730]:P<0.001)。在对其他变量进行校正后,不同年龄组的患者、男性和女性患者,或感染A或D基因型的患者之间均无统计学上的显著差异。
尽管e抗原阳性相对少见,但患有肝细胞癌的非洲黑人的乙型肝炎病毒载量较高。